Teachers Retirement System of The State of Kentucky Sells 1,413 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Teachers Retirement System of The State of Kentucky reduced its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 9.7% in the 3rd quarter, Holdings Channel reports. The fund owned 13,215 shares of the medical research company’s stock after selling 1,413 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in IQVIA were worth $3,132,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Simplify Asset Management Inc. raised its holdings in IQVIA by 67.8% during the 3rd quarter. Simplify Asset Management Inc. now owns 9,637 shares of the medical research company’s stock worth $2,284,000 after buying an additional 3,894 shares during the period. Raymond James & Associates raised its holdings in shares of IQVIA by 0.7% during the second quarter. Raymond James & Associates now owns 800,374 shares of the medical research company’s stock worth $169,231,000 after acquiring an additional 5,417 shares during the period. Versor Investments LP bought a new stake in IQVIA in the 3rd quarter valued at $1,328,000. CIBC Asset Management Inc increased its holdings in IQVIA by 3.3% during the 3rd quarter. CIBC Asset Management Inc now owns 263,752 shares of the medical research company’s stock worth $62,501,000 after purchasing an additional 8,490 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its stake in shares of IQVIA by 17.5% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 75,054 shares of the medical research company’s stock valued at $17,785,000 after purchasing an additional 11,170 shares during the period. Institutional investors and hedge funds own 89.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. The Goldman Sachs Group decreased their price objective on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a report on Friday, November 1st. BTIG Research lowered their price objective on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Barclays reduced their target price on shares of IQVIA from $260.00 to $255.00 and set an “overweight” rating for the company in a report on Friday, November 1st. Deutsche Bank Aktiengesellschaft cut their price target on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Finally, Morgan Stanley decreased their price objective on IQVIA from $280.00 to $265.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Four analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, IQVIA has an average rating of “Moderate Buy” and a consensus target price of $256.19.

IQVIA Stock Down 0.7 %

Shares of IQV opened at $199.06 on Friday. The firm’s 50-day simple moving average is $212.24 and its 200 day simple moving average is $224.21. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market cap of $36.13 billion, a P/E ratio of 26.12, a price-to-earnings-growth ratio of 2.07 and a beta of 1.49. IQVIA Holdings Inc. has a 52 week low of $187.62 and a 52 week high of $261.73.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.